In most regions of the world, antimicrobial resistance has increased to the point where
empirical standard triple therapy for Helicobacter pylori eradication is no longer …

Helicobacter pylori (H. pylori) is a common gastrointestinal bacterial strain closely
associated with the incidence of chronic gastritis, peptic ulcers, gastric mucosa-associated …

As one of the most prevalent infections globally, Helicobacter pylori (H. pylori) continues to
present diagnostic and therapeutic challenges for clinicians worldwide. Diagnostically, the …

Background Potassium‐competitive acid blockers (P‐CAB) are recommended for the
treatment of Helicobacter pylori infections, but dual therapy of P‐CAB with amoxicillin has …

Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …

OBJECTIVES: This study assessed the effectiveness, adverse events, patient adherence,
and costs of modified dual therapy compared with bismuth-containing quadruple therapy for …

AIM: To determine the resistance patterns of Helicobacter pylori (H. pylori) strains isolated
from patients in Beijing and monitor the change of antibiotic resistance over time …

Background & Aims The decline in Helicobacter pylori cure rates emphasizes the need for
readily available methods to determine antimicrobial susceptibility. Our aim was to compare …

Background The first-line eradication rate of standard triple therapy for Helicobacter pylori
infection has declined to< 80%, and alternative therapies with> 90% success rates are …